Goulet, Cassandra Ringuette
Champagne, Audrey
Bernard, Geneviève
Vandal, Dominique
Chabaud, Stéphane
Pouliot, Frédéric
Bolduc, Stéphane
Funding for this research was provided by:
Bladder Cancer Canada
Fonds de Recherche du Québec - Santé
Ferring
Institute of Musculoskeletal Health and Arthritis
Canadian Urological Association
Article History
Received: 30 May 2018
Accepted: 5 February 2019
First Online: 11 February 2019
Ethics approval and consent to participate
: Bladder biopsies from paediatric patients undergoing non-oncologic urologic surgery were obtained at the CHU de Québec-Université Laval Research Center in accordance with the institutional review board. All legal guardians of donors provided their formal, informed and written consent, each agreeing to supply a biopsy for this study.
: Not applicable.
: Frédéric Pouliot has received speaker’s bureau honoraria from Sanofi, Genzyme, Amgen, Astellas, and Janssen; he is a consultant/advisory board member of Sanofi, Abbvie, Astellas, Janssen, Genzyme and Roche. No potential conflicts of interest were disclosed by the other authors.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.